Figure 1
Comparison of the data on numbers of PMs and ICDs from national hospital discharge database with the data published in the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)_
| Slovenia | Austria | All UK England | Germany | Italy | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | EHRA | Hospitals | Diff | EHRA | Hospitals | Diff | EHRA | Hospitals | Diff | EHRA | Hospitals | Diff | EHRA | Hospitals | Diff |
| Pacemakers | |||||||||||||||
| 2008 | 1100 | 586 | -88% | 7570 | 7690 | 2% | 40570 | 37734 | -8% | 98300 | 89194 | -10% | 61300 | 62220 | 2% |
| 2009 | 935 | 652 | -43% | 7930 | 7500 | -6% | 39850 | 42701 | 7% | 102177 | 92215 | -11% | 63000 | 62215 | -1% |
| 2010 | 1153 | 602 | -92% | 7712 | 7589 | -2% | 37194 | 45636 | 18% | 103423 | 94659 | -9% | 63400 | 62202 | -2% |
| 2011 | 1295 | 604 | -114% | 7810 | 7870 | 1% | 38239 | 50540 | 24% | 106953 | 96013 | -11% | 63100 | 62141 | -2% |
| 2012 | 1333 | 667 | -100% | 7870 | 7950 | 1% | 38770 | 0 | 106567 | 96403 | -11% | 61300 | 62098 | 1% | |
| ICDs | |||||||||||||||
| 2008 | 96 | 103 | 7% | 1100 | 1104 | 0% | 7403 | 5086 | -46% | 21600 | 20948 | -3% | 18000 | 16554 | -8% |
| 2009 | 111 | 145 | 23% | 1290 | 1157 | -11% | 5077 | 5376 | 6% | 23574 | 22940 | -3% | 10500 | 15100 | 30% |
| 2010 | 101 | 176 | 43% | 1268 | 1176 | -8% | 5175 | 5344 | 3% | 25071 | 24422 | -3% | 11100 | 13933 | 20% |
| 2011 | 144 | 174 | 17% | 1805 | 1195 | -51% | 5404 | 5467 | 1% | 26579 | 25219 | -5% | 11970 | 14106 | 15% |
| 2012 | 122 | 196 | 38% | 1195 | 1296 | 8% | 5762 | 0 | 26536 | 25956 | -2% | 12000 | 13943 | 14% | |
Charlson Comorbidity Index – average of weighted CCI scores for each category of device, by country for the year 2011_
| Austria | England | Germany | Italy | Slovenia | ||
|---|---|---|---|---|---|---|
| Overall CCI scores | ||||||
| PM implants | 0.10 | 0.90 | 1.63 | 0.96 | 1.07 | |
| ICD implants | 0.58 | 1.32 | 2.50 | 1.27 | 1.52 | |
| PM implants | Acute myocardial infarction (AMI) | 1% | 1% | 9% | 5% | 6% |
| Congestive Heart Failure | 4% | 15% | 32% | 13% | 23% | |
| Diabetes | N/A | 17% | 20% | 11% | 22% | |
| ICD implants | AMI | 2% | 5% | 35% | 14% | 26% |
| Congestive Heart Failure | 54% | 60% | 91% | 73% | 63% | |
| Diabetes | 0% | 20% | 25% | 13% | 16% | |
Main reasons for difference in data in CIEDs uptake in 5 European countries (2008-2012)_
| The reason for the difference in the data | A description |
|---|---|
| The use of Australian coding system valid until 21 December in Slovenia |
|
| Only a partial link between financing and DRG coding in Slovenia |
|
| No golden rule for the optimal crude utilisation rate |
|
| Variations in relative indications, financial restrictions and other contextual factors across countries |
|
Main reasons for difference in PM and ICD implants crude utilization rate (number of devices/100_000 inhabitants) across 5 European countries, 2008-2012_
| Pacemaker implants | |||||
|---|---|---|---|---|---|
| Austria | England | Germany | Italy | Slovenia | |
| 2008 | 67.3 | 60.0 | 87.2 | 74.3 | 29.9 |
| 2009 | 66.5 | 68.9 | 90.6 | 74.6 | 32.7 |
| 2010 | 70.5 | 75.7 | 94.5 | 75.1 | 31.2 |
| 2011 | 71.0 | 84.1 | 96.0 | 75.8 | 29.7 |
| 2012 | 72.4 | N/A | 96.4 | 77.6 | 32.7 |
| AGR average growth rate | 1.84 | 11.91 | 2.54 | 1.09 | 2.26 |